OCUGEN, INC. Payments of Debt Issuance Costs
OCUGEN, INC. (OCGN) reported Payments of Debt Issuance Costs of $4.47 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2026-08-06
- OCUGEN, INC. payments of debt issuance costs for the quarter ending 2024-12-31 was $809.00K.
- OCUGEN, INC. payments of debt issuance costs for the quarter ending 2024-09-30 was $0.00.
- OCUGEN, INC. payments of debt issuance costs for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- OCUGEN, INC. payments of debt issuance costs for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- OCUGEN, INC. payments of debt issuance costs for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- OCUGEN, INC. payments of debt issuance costs for fiscal 2024 was $809.00K, a 1089.71% increase from fiscal 2023.
- OCUGEN, INC. payments of debt issuance costs for fiscal 2023 was $68.00K, a 58.14% increase from fiscal 2022.
- OCUGEN, INC. payments of debt issuance costs for fiscal 2022 was $43.00K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month | Payments of Debt Issuance Costs 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $4.47M 10-Q · filed 2026-08-06 | ||||
| 2025-12-31 | $0.00 10-K · filed 2026-03-04 | ||||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-06 | ||||
| 2024-12-31 | $809.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $809.00K derived: sum of 2 quarters · filed 2026-03-04 | $809.00K derived: sum of 3 quarters · filed 2026-03-04 | $809.00K 10-K · filed 2026-03-04 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 4 quarters · filed 2025-03-05 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | $0.00 derived: sum of 3 quarters · filed 2025-03-05 | $0.00 derived: sum of 4 quarters · filed 2025-03-05 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 | $0.00 derived: sum of 2 quarters · filed 2025-03-05 | $0.00 derived: sum of 3 quarters · filed 2025-03-05 | $6.00K derived: sum of 4 quarters · filed 2025-03-05 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $0.00 derived: sum of 2 quarters · filed 2025-03-05 | $6.00K derived: sum of 3 quarters · filed 2025-03-05 | $68.00K 10-K · filed 2025-03-05 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $6.00K derived: sum of 2 quarters · filed 2024-11-14 | $68.00K 10-Q · filed 2024-11-14 | $68.00K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $68.00K 10-Q · filed 2024-08-08 | $68.00K derived: sum of 3 quarters · filed 2024-08-08 | $111.00K derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | $62.00K 10-Q · filed 2024-05-14 | $62.00K derived: sum of 2 quarters · filed 2024-05-14 | $105.00K derived: sum of 3 quarters · filed 2024-05-14 | $105.00K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-K 9 month · filed 2024-04-16 | $43.00K derived: sum of 2 quarters · filed 2024-04-16 | $43.00K derived: sum of 3 quarters · filed 2024-04-16 | $43.00K 10-K · filed 2024-04-16 | |
| 2022-09-30 | $43.00K derived: 10-K 9 month − 10-K 6 month · filed 2024-04-16 | $43.00K derived: sum of 2 quarters · filed 2024-04-16 | $43.00K 10-K · filed 2024-04-16 | $43.00K derived: sum of 4 quarters · filed 2024-04-16 | |
| 2022-06-30 | $0.00 derived: 10-K 6 month − 10-K 3 month · filed 2024-04-16 | $0.00 10-K · filed 2024-04-16 | $0.00 derived: sum of 3 quarters · filed 2024-04-16 | $0.00 derived: sum of 4 quarters · filed 2024-04-16 | |
| 2022-03-31 | $0.00 10-K · filed 2024-04-16 | $0.00 derived: sum of 2 quarters · filed 2024-04-16 | $0.00 derived: sum of 3 quarters · filed 2024-04-16 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-28 | $0.00 10-K · filed 2023-02-28 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | |||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-06 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $6.00K 10-K · filed 2022-02-28 | $5.74K 10-K · filed 2021-03-19 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $6.00K 10-Q · filed 2021-11-09 | |||
| 2020-06-30 | $6.00K 10-Q · filed 2021-08-06 | ||||
| 2019-12-31 | -$23.26K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $99.00K 10-K · filed 2022-02-28 | $99.20K 10-K · filed 2020-03-27 | ||
| 2019-09-30 | $122.26K 10-Q · filed 2019-11-12 | ||||
| 2018-12-31 | $103.92K 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |